Unlocking the quiet zone: the small airway asthma phenotype (Q38217775)

31 August 2017

Unlocking the quiet zone: the small airway asthma phenotype (English)

1 reference

31 August 2017

0 references

1 reference

Brian Lipworth

1

1 reference

PubMed ID

24899370

31 August 2017

Arvind Manoharan

series ordinal

2

1 reference

PubMed ID

24899370

31 August 2017

William Anderson

series ordinal

3

1 reference

31 August 2017

1 June 2014

1 reference

The Lancet. Respiratory medicine

31 August 2017

1 reference

31 August 2017

2

1 reference

31 August 2017

6

1 reference

31 August 2017

497-506

1 reference

Resistance of central and peripheral airways measured by a retrograde catheter

31 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

The Lung's Quiet Zone

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Direct assessment of small airways reactivity in human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Small-airways dysfunction associates with respiratory symptoms and clinical features of asthma: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Pathogenesis of small airways in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Physiological measurement of the small airways

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Oscillation mechanics of lungs and chest in man

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

The forced oscillation technique in clinical practice: methodology, recommendations and future developments.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Respiratory impedance measurements for assessment of lung mechanics: focus on asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Are we overlooking persistent small airways dysfunction in community-managed asthma?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Less small airway dysfunction in asymptomatic bronchial hyperresponsiveness than in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Relationship between airway narrowing, patchy ventilation and lung mechanics in asthmatics.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Ventilation heterogeneity is a major determinant of airway hyperresponsiveness in asthma, independent of airway inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Relating small airways to asthma control by using impulse oscillometry in children

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Peripheral airway impairment measured by oscillometry predicts loss of asthma control in children

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

The utility of forced expiratory flow between 25% and 75% of vital capacity in predicting childhood asthma morbidity and severity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Nitrogen washout slope in poorly controlled asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Peripheral lung function in patients with stable and unstable asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

The role of the small airways in the clinical expression of asthma in adults

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Ventilation heterogeneity predicts asthma control in adults following inhaled corticosteroid dose titration

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Relationship between past airway pathology and current lung function in preschool wheezers

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Gas trapping is associated with severe exacerbation in asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Increase in alveolar nitric oxide in the presence of symptoms in childhood asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Clinical patterns in asthma based on proximal and distal airway nitric oxide categories

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Clinical significance of small airway obstruction markers in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Inflammation and airway function in the lung periphery of patients with stable asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

A simple technique to characterize proximal and peripheral nitric oxide exchange using constant flow exhalations and an axial diffusion model.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Both inflammation and remodeling influence nitric oxide output in children with refractory asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Central and peripheral airway/alveolar sites of exhaled nitric oxide in acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Effect of inhaled corticosteroids on small airways in asthma: investigation using impulse oscillometry.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Relationship of large and small airway response with inhaled corticosteroid to asthma control

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

The functional benefit of anti-inflammatory aerosols in the lung periphery.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Air trapping in mild and moderate asthma: effect of inhaled corticosteroids.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Both bronchial and alveolar exhaled nitric oxide are reduced with extrafine beclomethasone dipropionate in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Alveolar nitric oxide and asthma control in mild untreated asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Reply: To PMID 23639306.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone vs fluticasone dry powder inhaler on exhaled inflammatory markers in childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Inhaled and systemic corticosteroid response in severe asthma assessed by alveolar nitric oxide: a randomized crossover pilot study of add-on therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Hydrofluoroalkane-134A beclomethasone or chlorofluorocarbon fluticasone: effect on small airways in poorly controlled asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Effect of HFA-flunisolide on peripheral lung inflammation in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Ciclesonide improves measures of small airway involvement in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Localization of β2-adrenoceptor messenger RNA in human and rat lung using in situ hybridization: correlation with receptor autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Glucocorticoid receptor localization in normal and asthmatic lung

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Effects of extra-fine inhaled beclomethasone/formoterol on both large and small airways in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Effects on small airway obstruction of long-term treatments with beclomethasone/formoterol hydrofluoroalkane (metered-dose inhaler) versus fluticasone/salmeterol (dry-powder inhaler) in asthma: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Novel functional imaging of changes in small airways of patients treated with extrafine beclomethasone/formoterol.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Real life clinical study design supporting the effectiveness of extra-fine inhaled beclomethasone/formoterol at the level of small airways of asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Lung function and asthma control with beclomethasone and formoterol in a single inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Real-life prospective study on asthma control in Italy: cross-sectional phase results.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

1-year prospective real life monitoring of asthma control and quality of life in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970103-1

7 January 2021

10.1016/S2213-2600(14)70103-1

Identifiers

DOI

1 reference

31 August 2017

1 reference

PubMed ID

24899370